Table 1

Patients’ planned and actual treatment pathway

Gender	Age	MDT recommendation	Decided	Duration	Survival	Status
Female	72	Pall chemo	Pall chemo	No treatment	2 weeks	Deceased
Female	73	Pall chemo	Pall chemo	Stopped	3 weeks	Deceased
Female	71	Pall chemo	Pall chemo	3 of 4 cycles	4 months	Deceased
Female	67	Pall radio/chemo	Pall radio/no chemo	No chemo	1 year	Deceased
Female	61	Pall chemo/best supportive care	Best supportive care	No treatment	4 weeks	Deceased
Female	52	Pall chemo	Pall chemo	Completed	3 months	Deceased
Female	65	Pall chemo	Pall chemo	Stopped	6 weeks	Deceased
Male	59	Pall chemo	Pall chemo	Completed	3 months	Alive*
Male	70	Pall radio	Pall radio	Completed	9 months	Alive*
Male	80	Pall chemo/best supportive care	Best supportive care	No chemo	3 months	Deceased
Male	76	Pall chemo/trial	Pall chemo	4 cycles	1 month	Deceased
Male	66	Pall chemo/trial	Pall chemo	4 cycles	5 months	Deceased
Male	68	Pall chemo	Pall chemo	4 cycles then pall radio after 1 year	1 year/1 month	Deceased
Male	71	Pall chemo	No treatment	No treatment	4 months	Deceased
Male	65	Pall chemo/trial	Trial	Ongoing	3 months	Alive

*At end of study.
MDT, multidisciplinary team.